The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB),
including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB
correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system.
Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly
prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.
In celebration of PAAB's 50th Anniversary, Messenger is now FREE of charge with all new and ongoing ARO submissions until March 31, 2026!
Announcements
1
Posts
1
Posters
26
Views
